provider_review · verified 2026-09-14
Luvo Health review
Three NAD+ routes at one price, billed per four weeks not per month
Injection, drops and nasal spray cost the same at every term — and so does sermorelin, so the figure describes the commitment rather than the product.
How this site makes money
Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.
at_a_glance
- price
- Every NAD+ product page reads "Starting at $27 /week" — the fifty-two-week plan at $1,417 charged once.
- what you pay
- $199 for a four-week cycle at the entry term, which the pricing table prints as $50/week. The ladder then runs $507 per twelve weeks ($42/week), $894 per twenty-four ($37/week) and $1,417 per fifty-two ($27/week). Four weeks is not a month: thirteen cycles a year makes the entry term $2,587 annually.
- pharmacy
- Not named. Luvo describes compounded medications and states they are not FDA-approved, but identifies no dispensing facility and claims no 503A or 503B class.
- states
- Not enumerated on the pricing page.
- on our index
- Ranked #5 of 50 on our NAD+ provider index.
verdict
The short version
Luvo publishes more of its pricing than almost anything else ranked here: one table, four terms, every product, before any intake. It is what the table says that takes reading. NAD+ comes three ways — a weekly injection, oral drops and a nasal spray — and all three cost exactly the same at every rung: $199 for four weeks, $507 for twelve, $894 for twenty-four, $1,417 for fifty-two. So does sermorelin, at identical figures, which tells you the price is attached to the term rather than to the product you chose. Two things follow. The "starting at $27/week" on every NAD+ page is the fifty-two-week plan, $1,417 charged once; the entry term is $199, which is $50 a week. And the cycle is FOUR WEEKS, not a calendar month — thirteen charges a year, so $199 a cycle is $2,587 annually rather than the $2,388 a monthly reading suggests. To its credit Luvo states the four-week basis in the table itself rather than leaving it to the terms, and every advertised weekly figure divides exactly out of its block price.
evidence
What the evidence for this route shows
The pricing is unusually transparent; the therapy is not unusually well evidenced. Compounded NAD+ has no rigorous human trial support by injection, by oral drops or by nasal spray, and paying for fifty-two weeks up front does not change that.
pricing
What it actually costs
- advertised
- Every NAD+ product page reads "Starting at $27 /week" — the fifty-two-week plan at $1,417 charged once.
- you pay
- $199 for a four-week cycle at the entry term, which the pricing table prints as $50/week. The ladder then runs $507 per twelve weeks ($42/week), $894 per twenty-four ($37/week) and $1,417 per fifty-two ($27/week). Four weeks is not a month: thirteen cycles a year makes the entry term $2,587 annually.
- the catch
- Two. The advertised figure is the longest commitment, fifty-two weeks paid in one charge. And the unit is a four-week cycle rather than a calendar month, so any comparison against a monthly seller understates Luvo by one charge a year unless it is converted first.
Other money you will meet
- Prices are per block and charged once per term, not monthly installments
- No membership fee is published; the clinician review is inside the program price
- All three NAD+ formats and sermorelin carry identical prices at identical terms
source :: read at luvohealth.com on 2026-09-14, in a browser that runs JavaScript.
fit
Who this is and is not for
Buy it if
- You want a needle-free route at no premium — drops and spray cost what the injection costs
- You want every term for every product published in one table before any intake
- You want the billing cycle stated where the price is, rather than in a terms page
- You have already decided on a long term, where the per-week figure genuinely falls
Look elsewhere if
- You are budgeting from "$27/week" — that is fifty-two weeks paid up front
- You are comparing against a monthly seller and have not converted for thirteen cycles a year
- You expect the format you choose to affect the price; here it does not
- You want the pharmacy named or its compounding class stated
included
What is inside the price
- consult
- Inside the program price — Luvo describes clinician-guided care with no separate consultation charge published.
- labs
- Not published as required, and not priced.
- follow-ups
- Described as ongoing clinician guidance within the program.
- human support
- Clinician-guided programme; no coach or nurse is named separately.
- supplies
- Not itemized on the pricing table.
- shipping
- Not itemized on the pricing table.
the_knock
What they would rather you skipped
The $27 a week on every NAD+ page is fifty-two weeks paid in a single $1,417 charge, and the cycle underneath every rung is four weeks rather than a calendar month — thirteen charges a year, which quietly adds one to any comparison a reader makes against a monthly seller. The entry term is $199, or $50 a week, nearly double the advertised figure. And because the injection, the drops, the nasal spray and sermorelin all carry identical prices at identical terms, the table cannot tell you anything about the product you are actually choosing.
And the rest
- No pharmacy is named and no compounding class is stated
- The state list is not published on the pricing page
- Identical pricing across formats means the table cannot tell you what a route costs to make
- No milligram or bottle volume is published against any of the three NAD+ formats
- The four-week cycle is easy to miss in a table that otherwise reads like monthly pricing
tools
Work out your own number
Every figure on this page was read on Luvo Health’s own site on 2026-09-14 in a browser that runs JavaScript, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.